Pharmacy benefit manager Express Scripts Holding Co. will roll out a value-based purchasing program in 2018 in the pulmonary drug category that will leverage the competition offered by an expected generic version of GlaxoSmithKline PLC's Advair Diskus (fluticasone/salmeterol) to lower costs.
"Our clients are clamoring from some reprieve from Advair in asthma, pulmonary conditions. So that will be the cornerstone of...






